May 17th, 2019
•The transimmunization (TI) device or plate and related protocols have been developed to replicate the key features of extracorporeal photochemotherapy (ECP), in an experimental setting, allowing for production of physiologically activated, tunable dendritic cells (DCs) for cancer immunotherapy.
Tags
Video correlati
Optimized Protocol for Efficient Transfection of Dendritic Cells without Cell Maturation
Generation and Labeling of Murine Bone Marrow-derived Dendritic Cells with Qdot Nanocrystals for Tracking Studies
Isolation of Mouse Lung Dendritic Cells
Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy
Isolating And Immunostaining Lymphocytes and Dendritic Cells from Murine Peyer's Patches
Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells
Isolation of Myeloid Dendritic Cells and Epithelial Cells from Human Thymus
T Cells Capture Bacteria by Transinfection from Dendritic Cells
Generation of Immature, Mature and Tolerogenic Dendritic Cells with Differing Metabolic Phenotypes
Generation of Human Monocyte-derived Dendritic Cells from Whole Blood